RIMONDI, Erika
 Distribuzione geografica
Continente #
NA - Nord America 3.645
EU - Europa 1.019
AS - Asia 675
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 5.346
Nazione #
US - Stati Uniti d'America 3.633
IT - Italia 294
CN - Cina 289
SG - Singapore 194
PL - Polonia 184
UA - Ucraina 162
DE - Germania 135
TR - Turchia 104
GB - Regno Unito 93
ID - Indonesia 50
SE - Svezia 45
FI - Finlandia 42
FR - Francia 17
VN - Vietnam 15
BE - Belgio 14
CA - Canada 12
RU - Federazione Russa 12
CZ - Repubblica Ceca 11
HK - Hong Kong 8
IN - India 6
LT - Lituania 4
AU - Australia 3
IR - Iran 3
NL - Olanda 3
IE - Irlanda 2
MY - Malesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
Totale 5.346
Città #
Fairfield 533
Woodbridge 487
Houston 275
Ashburn 267
Seattle 226
Chandler 218
Ann Arbor 203
Wilmington 196
Jacksonville 189
Cambridge 187
Warsaw 184
Singapore 160
Ferrara 141
Santa Clara 137
Beijing 71
Izmir 63
Princeton 59
Jakarta 50
New York 47
Nanjing 46
San Diego 42
Boardman 35
Milan 34
Shanghai 34
Los Angeles 22
Nanchang 20
Falls Church 19
Shenyang 16
Dearborn 15
Dong Ket 15
Brussels 14
Bologna 11
Ferrara di Monte Baldo 11
London 11
Brno 10
Auburn Hills 9
Hebei 9
Jiaxing 9
San Mateo 9
Tianjin 9
Bremen 8
Changsha 8
Norwalk 8
Rome 8
Kunming 7
Mountain View 7
Toronto 7
Zhengzhou 7
Aprilia 6
Hong Kong 6
Jinan 6
Munich 6
Chicago 5
Ningbo 5
Orange 5
Ottawa 5
Tappahannock 5
Washington 5
Frankfurt am Main 4
Guangzhou 4
Helsinki 4
Leawood 4
Parma 4
Acton 3
Addison 3
Bari 3
Bentivoglio 3
Des Moines 3
Indiana 3
Lappeenranta 3
Meerut 3
Philadelphia 3
Redmond 3
Redwood City 3
Trieste 3
Verona 3
Andover 2
Ardabil 2
Augusta 2
Bassano Del Grappa 2
Brescia 2
Bucine 2
Castellanza 2
Forlì 2
Haikou 2
Hefei 2
Kilburn 2
Modena 2
Monmouth Junction 2
New Delhi 2
Padova 2
Palermo 2
San Francisco 2
Tolentino 2
Wandsworth 2
Aquileia 1
Azzano Decimo 1
Baku 1
Barcelona 1
Canberra 1
Totale 4.309
Nome #
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 175
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 168
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 161
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 159
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 157
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 149
Nutlin-3 upregulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feed-back anti-apoptotic mechanism 131
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 129
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 128
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 121
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 120
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 120
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 116
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL 115
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 115
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions. 112
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 111
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 110
Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin: Letter to the editor 107
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL). 106
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 104
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 102
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1. 101
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 101
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 101
Factors Predictive of Double Anterior Chamber Formation Following Deep Anterior Lamellar Keratoplasty 97
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema 95
null 92
A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment 92
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 91
null 90
null 90
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 90
Activation of the p53 pathway down-regulates the osteoprotegerin (OPG) expression and release by vascular endothelial cells. 90
Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Show a Long-term Stability in the Breast Milk of Mothers of Preterm Infants 89
TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end-points: induction of apoptosis and PGE2 release. 88
null 88
null 86
Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study 86
null 83
null 76
null 69
Role of vitamin D in the pathogenesis of atheromatosis 63
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 60
null 55
null 44
null 42
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 41
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 37
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 36
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 34
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 34
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 32
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 32
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 32
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 29
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 27
Ultrastructural Alterations of Grafted Corneal Buttons: The Anatomic Basis for Stromal Peeling Along a Natural Plane of Separation 27
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 25
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 25
The role of the mTOR pathway in diabetic retinopathy 23
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 23
MitoQ is able to modulate apoptosis and inflammation 22
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts 20
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 18
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 17
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 17
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 17
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 16
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 14
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 14
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 12
Totale 5.499
Categoria #
all - tutte 27.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020784 0 0 0 0 84 122 121 134 114 120 48 41
2020/2021918 45 66 27 118 89 118 57 101 39 133 81 44
2021/2022615 28 54 25 21 56 48 56 37 21 55 60 154
2022/2023523 58 32 23 59 77 74 34 46 71 2 29 18
2023/2024375 33 39 13 12 20 57 16 41 1 23 16 104
2024/2025501 42 30 132 90 207 0 0 0 0 0 0 0
Totale 5.499